Nutritional treatment of cancer cachexia;Prise en charge nutritionnelle et médicamenteuse de la cachexie cancéreuse

Nutrition Clinique et Metabolisme

Volumn 20, Issue 3, 2006, Pages 133-136

  Raynard, Bruno ^a   Antoun, Sami ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cachexy; Cancer; Fatty acids n 3; Oral nutritional complements; The dietetic Council

Indexed keywords

ANTINEOPLASTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEDROXYPROGESTERONE ACETATE; MELATONIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PROSTAGLANDIN SYNTHASE INHIBITOR; THALIDOMIDE; TRACE ELEMENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTICLE; CACHEXIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DIET SUPPLEMENTATION; DIET THERAPY; HUMAN; INSULIN RESISTANCE;

EID: 33748948240     PISSN: 09850562     EISSN: 17683092     Source Type: Journal    
DOI: 10.1016/j.nupar.2006.07.006     Document Type: Article

References (23)

1. Nitenberg G., and Raynard B. Nutritional support of the cancer patient: issues and dilemmas. Crit. Rev. Oncol. Hematol. 34 (2000) 137-168
2. VAN Bockhorst-de van der Schueren M.A.E. Nutritional support strategies for malnourished cancer patients. Eur. J. Oncol. Nurs. 9 suppl 2 (2005) S74-S83
3. Fearon K., von Meyenfeldt L.F., Moses A.G., et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 52 (2003) 1479-1486
4. Barber M.D., Ross J.A., Voss A.C., et al. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br. J. Cancer 81 (1999) 80-86
5. Bruera J., Strasser F., Palmer J.L., et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J. Clin. Oncol. 21 (2003) 129-134
6. Hardmann W.E. (n-3) fatty acids and cancer therapy. J. Nutr. 134 12 Suppl (2004) 3427S-3430S
7. Bougnoux P., Maillard V., Chajes V., et al. Omega-6/omega-3 polyunsaturated fatty acids ratio and breast cancer. World Rev. Nutr. Diet. 94 (2005) 158-165
8. Jatoi A. Fish oil, lean tissue, and cancer: is there a role for eicosapentaenoic acid in treating the cancer anorexia/weight loss syndrome?. Crit. Rev. Oncol. Hematol. 55 (2005) 37-43
9. Gogos G.A., Ginopoulos P., Salsa B., et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 82 (1998) 395-402
10. Barber M.D., Preston T., McMillan D.C., et al. Modulation of the liver export protein synthetic response to feeding by an n-3 fatty-acid-enriched nutritional supplement is associated with anabolism in cachectic cancer patients. Clin. Sci. 106 (2004) 359-364
11. Barber M.D., McMillan D.C., Preston T., et al. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin. Sci. 98 (2000) 389-399
12. Moses A.W.G., Slater C., Preston T., et al. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br. J. Cancer 90 (2004) 996-1002
13. Russell S.T., and Tisdale M. Effect of eicosapentaenoic acid (EPA) on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia. Prostaglandins Leukot. Essent. Fatty Acids 72 (2005) 409-414
14. Zuijdgeest-Van Leeuwen S.D., Dagnelie P.C., Wattimena J.L., et al. Eicosapentaenoic acid ethyl ester supplementation in cachectic cancer patients and healthy subjects: effects on lipolysis and lipid oxidation. Clin. Nutr. 19 (2000) 417-423
15. Whitehouse A.S., Smith H.J., Drake J.L., and Tisdale M.J. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Res. 61 (2001) 3604-3609
16. Smith H.J., Greenberg N.A., and Tisdale M.J. Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice. Br. J. Cancer 91 (2004) 408-412
17. Antoun S., Merad S., Nitenberg G., et al. Acides gras n-3 et cancer déclaré : intérêt réel ou effet de mode ?. Nutr. Clin. Metab. 19 (2005) 160-165
18. Elia M., Van Bokhorst-de van der Schueren M.A., Garvey J., et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int. J. Oncol. 28 (2006) 5-23
19. Gordon J.N., Trebble T.M., Ellis R.D., et al. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut 54 (2005) 540-545
20. Persson C., Glimelius B., Ronnelid J., and Nygren P. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study. Nutrition 21 (2005) 170-178
21. Lundholm K., Daneryd P., Bosaeus I., et al. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function. Cancer 100 (2004) 1967-1977
22. Cerchietti L.C., Navigante A.H., Peluffo G.D., et al. Effects of celecoxib, medroxyprogesterone, and dietary intervention on systemic syndromes in patients with advanced lung adenocarcinoma: a pilot study. J Pain Symp Manag 27 (2004) 85-95
23. Tone C.M., Cardoza D.M., Carpenter R.H., et al. Long-term effects of plasmid-mediated growth hormone releasing hormone in dogs. Cancer Gene Ther. 11 (2004) 389-396